49 selected items - PubMed

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

<< First< Prev

Page of 3

Results: 1 to 20 of 49

Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.

Waldmann A, Nolte S, Weinstock MA, Breitbart EW, Eisemann N, Geller AC, Greinert R, Volkmer B, Katalinic A.

Br J Cancer. 2012 Feb 28;106(5):970-4. doi: 10.1038/bjc.2012.22. Epub 2012 Jan 31.

PMID:: 22294187; [PubMed - indexed for MEDLINE]

Related citations

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level.

Sakaizawa K, Goto Y, Kiniwa Y, Uchiyama A, Harada K, Shimada S, Saida T, Ferrone S, Takata M, Uhara H, Okuyama R.

Br J Cancer. 2012 Feb 28;106(5):939-46. doi: 10.1038/bjc.2012.12. Epub 2012 Jan 26.

PMID:: 22281663; [PubMed - indexed for MEDLINE]

Related citations

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.

Xu Y, Brenn T, Brown ER, Doherty V, Melton DW.

Br J Cancer. 2012 Jan 31;106(3):553-61. doi: 10.1038/bjc.2011.568. Epub 2012 Jan 5.

PMID:: 22223089; [PubMed - indexed for MEDLINE]

Related citations

13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010.

Parkin DM, Mesher D, Sasieni P.

Br J Cancer. 2011 Dec 6;105 Suppl 2:S66-9. doi: 10.1038/bjc.2011.486. No abstract available.

PMID:: 22158324; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.

Algazi AP, Weber JS, Andrews SC, Urbas P, Munster PN, DeConti RC, Hwang J, Sondak VK, Messina JL, McCalmont T, Daud AI.

Br J Cancer. 2012 Jan 3;106(1):85-91. doi: 10.1038/bjc.2011.514. Epub 2011 Nov 29.

PMID:: 22127285; [PubMed - indexed for MEDLINE]

Related citations

High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives.

Janjetovic Z, Brozyna AA, Tuckey RC, Kim TK, Nguyen MN, Jozwicki W, Pfeffer SR, Pfeffer LM, Slominski AT.

Br J Cancer. 2011 Dec 6;105(12):1874-84. doi: 10.1038/bjc.2011.458. Epub 2011 Nov 17.

PMID:: 22095230; [PubMed - indexed for MEDLINE]

Related citations

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.

Journe F, Id Boufker H, Van Kempen L, Galibert MD, Wiedig M, Salès F, Theunis A, Nonclercq D, Frau A, Laurent G, Awada A, Ghanem G.

Br J Cancer. 2011 Nov 22;105(11):1726-32. doi: 10.1038/bjc.2011.451. Epub 2011 Nov 1.

PMID:: 22045183; [PubMed - indexed for MEDLINE]

Related citations

Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy.

Keidar M, Walk R, Shashurin A, Srinivasan P, Sandler A, Dasgupta S, Ravi R, Guerrero-Preston R, Trink B.

Br J Cancer. 2011 Oct 25;105(9):1295-301. doi: 10.1038/bjc.2011.386. Epub 2011 Oct 6.

PMID:: 21979421; [PubMed - indexed for MEDLINE]

Related citations

Birth characteristics and childhood carcinomas.

Johnson KJ, Carozza SE, Chow EJ, Fox EE, Horel S, McLaughlin CC, Mueller BA, Puumala SE, Reynolds P, Von Behren J, Spector LG.

Br J Cancer. 2011 Oct 25;105(9):1396-401. doi: 10.1038/bjc.2011.359. Epub 2011 Sep 13.

PMID:: 21915125; [PubMed - indexed for MEDLINE]

Related citations

10.

Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production.

Fukuda H, Mochizuki S, Abe H, Okano HJ, Hara-Miyauchi C, Okano H, Yamaguchi N, Nakayama M, D'Armiento J, Okada Y.

Br J Cancer. 2011 Nov 8;105(10):1615-24. doi: 10.1038/bjc.2011.431. Epub 2011 Oct 20.

PMID:: 22015555; [PubMed - indexed for MEDLINE]

Related citations

11.

miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions.

Grignol V, Fairchild ET, Zimmerer JM, Lesinski GB, Walker MJ, Magro CM, Kacher JE, Karpa VI, Clark J, Nuovo G, Lehman A, Volinia S, Agnese DM, Croce CM, Carson WE 3rd.

Br J Cancer. 2011 Sep 27;105(7):1023-9. doi: 10.1038/bjc.2011.288. Epub 2011 Aug 23.

PMID:: 21863027; [PubMed - indexed for MEDLINE]

Related citations

12.

Immune activation by combination human lymphokine-activated killer and dendritic cell therapy.

West EJ, Scott KJ, Jennings VA, Melcher AA.

Br J Cancer. 2011 Sep 6;105(6):787-95. doi: 10.1038/bjc.2011.290. Epub 2011 Aug 16.

PMID:: 21847125; [PubMed - indexed for MEDLINE]

Related citations

13.

Expression and functional role of CRIPTO-1 in cutaneous melanoma.

De Luca A, Lamura L, Strizzi L, Roma C, D'Antonio A, Margaryan N, Pirozzi G, Hsu MY, Botti G, Mari E, Hendrix MJ, Salomon DS, Normanno N.

Br J Cancer. 2011 Sep 27;105(7):1030-8. doi: 10.1038/bjc.2011.324. Epub 2011 Aug 23.

PMID:: 21863025; [PubMed - indexed for MEDLINE]

Related citations

14.

Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours.

Tawbi HA, Villaruz L, Tarhini A, Moschos S, Sulecki M, Viverette F, Shipe-Spotloe J, Radkowski R, Kirkwood JM.

Br J Cancer. 2011 Sep 6;105(6):773-7. doi: 10.1038/bjc.2011.285. Epub 2011 Aug 2.

PMID:: 21811257; [PubMed - indexed for MEDLINE]

Related citations

15.

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma.

O'Day S, Pavlick A, Loquai C, Lawson D, Gutzmer R, Richards J, Schadendorf D, Thompson JA, Gonzalez R, Trefzer U, Mohr P, Ottensmeier C, Chao D, Zhong B, de Boer CJ, Uhlar C, Marshall D, Gore ME, Lang Z, Hait W, Ho P; CNTO 95 Investigators.

Br J Cancer. 2011 Jul 26;105(3):346-52. doi: 10.1038/bjc.2011.183. Epub 2011 Jul 12.

PMID:: 21750555; [PubMed - indexed for MEDLINE]

Related citations

16.

Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies.

Eisen T, Marais R, Affolter A, Lorigan P, Robert C, Corrie P, Ottensmeier C, Chevreau C, Chao D, Nathan PD, Jouary T, Harries M, Negrier S, Montegriffo E, Ahmad T, Gibbens I, James MG, Strauss UP, Prendergast S, Gore ME.

Br J Cancer. 2011 Jul 26;105(3):353-9. doi: 10.1038/bjc.2011.257. Epub 2011 Jul 12.

PMID:: 21750549; [PubMed - indexed for MEDLINE]

Related citations

17.

Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma.

Gremel G, Ryan D, Rafferty M, Lanigan F, Hegarty S, Lavelle M, Murphy I, Unwin L, Joyce C, Faller W, McDermott EW, Sheahan K, Ponten F, Gallagher WM.

Br J Cancer. 2011 Aug 9;105(4):565-74. doi: 10.1038/bjc.2011.249. Epub 2011 Jul 5.

PMID:: 21730974; [PubMed - indexed for MEDLINE]

Related citations

18.

Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success?

Sigalotti L, Fratta E, Parisi G, Coral S, Maio M.

Br J Cancer. 2011 Jul 12;105(2):327-8. doi: 10.1038/bjc.2011.239. Epub 2011 Jun 21. No abstract available.

PMID:: 21694724; [PubMed - indexed for MEDLINE]

Related citations

19.

CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration.

Braig S, Wallner S, Junglas B, Fuchshofer R, Bosserhoff AK.

Br J Cancer. 2011 Jul 12;105(2):231-8. doi: 10.1038/bjc.2011.226. Epub 2011 Jun 14.

PMID:: 21673687; [PubMed - indexed for MEDLINE]

Related citations

20.

HOXC11-SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib.

deBlacam C, Byrne C, Hughes E, McIlroy M, Bane F, Hill AD, Young LS.

Br J Cancer. 2011 Jun 28;105(1):118-23. doi: 10.1038/bjc.2011.193. Epub 2011 Jun 7.

PMID:: 21654685; [PubMed - indexed for MEDLINE]

Related citations

<< First< Prev

Page of 3

Next >Last >>

Supplemental Content

Filters: Manage Filters

Find related data

Recent activity

Clear Turn Off Turn On

Skin cancer screening participation and impact on melanoma incidence in Germany-...
Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
Br J Cancer. 2012 Feb 28 ;106(5):970-4. doi: 10.1038/bjc.2012.22. Epub 2012 Jan 31 .

PubMed
A separate department of health in Washington State: four years before the mast.
A separate department of health in Washington State: four years before the mast.
J Public Health Policy. 1990 Autumn ;11(3):305-15.

PubMed
[Histoplasmosis: uncommon opportunistic infection in a patient ...
[Histoplasmosis: uncommon opportunistic infection in a patient with HIV infection].
Dtsch Med Wochenschr. 2012 Feb ;137(6):260-4. Epub 2012 Jan 31 .

PubMed
Everolimus exhibits efficacy as a radiosensitizer in a model of non-small ...
Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer.
Oncol Rep. 2012 May ;27(5):1625-9. doi: 10.3892/or.2012.1666. Epub 2012 Jan 27 .

PubMed
Identification of genes potentially involved in bone metastasis by genome-wide ...
Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice.
Int J Oncol. 2012 May ;40(5):1455-69. doi: 10.3892/ijo.2012.1348. Epub 2012 Jan 27 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

You are here: NCBI > Literature > PubMed

Write to the Help Desk

PubMed

Result Filters

Display Settings:

Send to:

Results: 1 to 20 of 49

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information